Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
3.320
-0.040 (-1.19%)
Oct 14, 2026, 11:48 AM EDT - Market open
Jupiter Neurosciences Market Cap
Jupiter Neurosciences has a market cap or net worth of $4.38 million as of October 14, 2026. It is the 45,488th most valuable company in the world and the 6,111th biggest in the United States. Its market cap has decreased by 91.33% in one year.
Market Cap
4.38M
Enterprise Value
4.60M
1-Year Change
-91.33%
Global Rank
Country Rank
#6,111 United States
Category
ChartMarket Cap Chart
Since the IPO on December 3, 2024, Jupiter Neurosciences's market cap has decreased from $132.40M to $4.38M, a decrease of -96.69%. That is a compound annual growth rate of -83.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 4.38M | -87.53% |
| Dec 31, 2025 | 35.11M | -90.09% |
| Dec 31, 2024 | 354.21M | 167.54% |
| Dec 3, 2024 | 132.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NuCana | 4.65M |
| Liminatus Pharma | 4.63M |
| PharmaCyte Biotech | 3.92M |
| Moolec Science | 3.74M |
| Ernexa Therapeutics | 3.61M |
| Dermata Therapeutics | 3.58M |
| Addex Therapeutics | 3.57M |
| Calidi Biotherapeutics | 3.51M |